Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Stem Cell Culture01:17

Stem Cell Culture

6.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.

Arteriosclerosis, thrombosis, and vascular biology·2013
Same author

Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

Thrombosis journal·2013
Same author

[Mechanisms of resistance to EML4-ALK inhibitors in non-small cell lung cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2013
Same author

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

Digestive diseases and sciences·2013
Same author

[Low-grade extraskeletal osteosarcoma of mediastinum: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2013
Same author

MedTxting: learning based and knowledge rich SMS-style medical text contraction.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2013

Related Experiment Video

Updated: Mar 8, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

5.0K

Stem cell therapy for ischemic heart diseases.

Hong Yu1,2, Kai Lu1,2,3, Jinyun Zhu1,2

  • 1Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, 310009, P.R. China.

British Medical Bulletin
|February 7, 2017
PubMed
Summary

Stem cell therapy shows promise for treating heart damage after myocardial infarction. Research is exploring stem cell-derived exosomes for more effective, cell-free treatments for ischemic heart diseases.

Keywords:
angiogenesisexosomegenetic modificationischemic heart diseasespreconditioningstem cellstransplantation

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.3K
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.8K

Related Experiment Videos

Last Updated: Mar 8, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

5.0K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.3K
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.8K

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Biotechnology

Background:

  • Ischemic heart diseases, particularly myocardial infarction, are a leading cause of heart failure (HF).
  • Current HF treatments delay progression but do not repair damaged heart tissue.
  • Heart transplantation is limited by donor availability, necessitating alternative therapies.

Purpose of the Study:

  • To review the potential of stem cell-based therapies for repairing myocardial damage.
  • To identify areas of agreement and controversy in current stem cell therapy research for ischemic heart disease.
  • To highlight emerging research directions, including stem cell-derived exosomes and cell reprogramming.

Main Methods:

  • Literature review of recent publications.
  • Analysis of data from ClinicalTrials.gov.
  • Synthesis of findings on stem cell types, delivery methods, and mechanisms of action.

Main Results:

  • Stem cell-based therapy is a promising strategy for damaged myocardium, with various stem cell types showing potential.
  • Significant variability exists in the efficacy of cell therapies, influenced by cell type, source, delivery, and dosage.
  • Stem cell-derived exosomes are emerging as key players in paracrine mechanisms and offer potential for cell-free therapy.

Conclusions:

  • Stem cell-based therapy holds significant promise for treating ischemic heart diseases and heart failure.
  • Further research into optimizing cell types, delivery, and understanding mechanisms is crucial.
  • Exosomes derived from stem cells represent a promising avenue for future cell-free therapeutic strategies in cardiovascular disease.